Cargando…

Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery

BACKGROUND: We aimed to explore the clinical benefit of adjuvant chemotherapy (AC) with fluoropyrimidine in patients with ypT0-3N0 rectal cancer after preoperative chemoradiation therapy (CRT) followed by total mesorectal excision (TME). METHODS: Patients with ypT0-3N0 rectal cancer after preoperati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Chang Gon, Ahn, Joong Bae, Shin, Sang Joon, Beom, Seung Hoon, Heo, Su Jin, Park, Hyung Soon, Kim, Jee Hung, Choe, Eun Ah, Koom, Woong Sub, Hur, Hyuk, Min, Byung Soh, Kim, Nam Kyu, Kim, Hoguen, Kim, Chan, Jung, Inkyung, Jung, Minkyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581409/ https://www.ncbi.nlm.nih.gov/pubmed/28865435 http://dx.doi.org/10.1186/s12885-017-3624-7

Ejemplares similares

Impact of adjuvant chemotherapy on patients with ypT0–2 ypN0 rectal cancer after neoadjuvant chemoradiation: a cohort study from a tertiary referral hospital
por: Galata, Christian, et al.
Publicado: (2018)

Evaluating the benefit of adjuvant chemotherapy in patients with ypT0–1 rectal cancer treated with preoperative chemoradiotherapy
por: Jeon, Ye Won, et al.
Publicado: (2021)

Oncologic Safety of Local Excision Compared With Total Mesorectal Excision for ypT0-T1 Rectal Cancer: A Propensity Score Analysis
por: Jung, Sung Min, et al.
Publicado: (2016)

YpT1-2N0 rectal cancer after neoadjuvant chemoradiation has lower survival compared with pT1-2N0 rectal cancer
por: Wan, Jue-feng, et al.
Publicado: (2015)

Multiple brain metastases in a patient with ypT0N0 micropapillary urothelial carcinoma of the bladder
por: Kuppa, Srikar, et al.
Publicado: (2021)

Complete pathological response (ypT0N0M0) after preoperative chemotherapy alone for stage IV rectal cancer
por: Naiken, Surennaidoo P, et al.
Publicado: (2014)

Predicting stage ypT0–1N0 for nonradical management in patients with middle or low rectal cancer who undergo neoadjuvant chemoradiotherapy: a retrospective cohort study
por: Lee, Jeehye, et al.
Publicado: (2022)

Is adjuvant chemotherapy necessary for patients with ypT0–2N0 rectal cancer treated with neoadjuvant chemoradiotherapy and curative surgery?
por: Lu, Zhao, et al.
Publicado: (2018)

Comparison between Local Excision and Radical Resection for the Treatment of Rectal Cancer in ypT0-1 Patients: An Analysis of the Clinicopathological Factors and Survival Rates
por: Oh, Soo Young, et al.
Publicado: (2021)

Does postoperative chemotherapy improve overall survival of patients with ypT1-2N0 cancer?
por: Su, Pengfei, et al.
Publicado: (2022)

Tumor budding outperforms ypT and ypN classification in predicting outcome of rectal cancer after neoadjuvant chemoradiotherapy
por: Trotsyuk, Iryna, et al.
Publicado: (2019)

Adjuvant chemotherapy may be unnecessary for ypT0-2N0 gastric cancer patients after neoadjuvant chemotherapy and curative gastrectomy
por: Shao, Xinxin, et al.
Publicado: (2023)

Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers
por: Kim, Chang Gon, et al.
Publicado: (2016)

Oncologic effects of adjuvant chemotherapy in patients with ypT0–2N0 rectal cancer after neoadjuvant chemoradiotherapy and curative surgery: a meta-analysis
por: Ha, Gi Won, et al.
Publicado: (2020)

Upfront Systemic Chemotherapy and Short-Course Radiotherapy with Delayed Surgery for Locally Advanced Rectal Cancer with Distant Metastases: Outcomes, Compliance, and Favorable Prognostic Factors
por: Yoon, Hong In, et al.
Publicado: (2016)

Endoscopy and magnetic resonance imaging-based prediction of ypT stage in patients with rectal cancer who received chemoradiotherapy: Results from a prospective study of 110 patients
por: Cho, Min Soo, et al.
Publicado: (2019)

Adjuvant chemotherapy and survival outcomes in rectal cancer patients with good response (ypT0-2N0) after neoadjuvant chemoradiotherapy and surgery: A retrospective nationwide analysis
por: Kuo, Yu-Hsuan, et al.
Publicado: (2022)

A Dilemma in Staging of Esophageal Cancer: How Should We Stage ypT0 N2 M0 Esophageal Cancer after Neoadjuvant Therapy?
por: Celik, Sebahattin, et al.
Publicado: (2015)

MRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection
por: Kim, Honsoul, et al.
Publicado: (2016)

Nomogram to predict ypN status after chemoradiation in patients with locally advanced rectal cancer
por: Jwa, E, et al.
Publicado: (2014)

ypT0 gastric carcinoma after preoperative chemotherapy: a unique status according to AJCC 8(th) edition cancer staging system
por: Zhu, Kankai, et al.
Publicado: (2020)

Nomogram for prediction of pathologic complete remission using biomarker expression and endoscopic finding after preoperative chemoradiotherapy in rectal cancer
por: Hur, Hyuk, et al.
Publicado: (2020)

The location of locoregional recurrence in pathologic T3N0, non-irradiated lower rectal cancer
por: Kim, Mi Sun, et al.
Publicado: (2013)

The Benefit of Post-Mastectomy Radiotherapy in ypN0 Patients after Neoadjuvant Chemotherapy According to Molecular Subtypes
por: Cho, Won Kyung, et al.
Publicado: (2019)

The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy
por: Cui, Jian, et al.
Publicado: (2017)

Prognostic factors for survival in esophageal squamous cell carcinoma (ESCC) patients with a complete regression of the primary tumor (ypT0) after neoadjuvant chemoradiotherapy (NCRT) followed by surgery
por: Kong, Min, et al.
Publicado: (2020)

Correction: The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy
por: Cui, Jian, et al.
Publicado: (2019)

Selective use of adjuvant chemotherapy for rectal cancer patients with ypN0
por: You, Kai-yun, et al.
Publicado: (2014)

MR prediction of pathologic complete response and early-stage rectal cancer after neoadjuvant chemoradiation in patients with clinical T1/T2 rectal cancer for organ saving strategy
por: Bae, Heejin, et al.
Publicado: (2020)

The prognostic differences and the effect of postmastectomy radiotherapy between post‐chemotherapy ypT1‐2ypN1 and de novo pT1‐2N1 breast cancer
por: Yang, Tian, et al.
Publicado: (2023)

Short-Term Outcomes and Cost-Effectiveness between Long-Course Chemoradiation and Short-Course Radiotherapy for Locally Advanced Rectal Cancer
por: Cho, Min Soo, et al.
Publicado: (2023)

Are you treating ypN0 patient with adjuvant abemaciclib?
por: Toss, A., et al.
Publicado: (2023)

Short- and long-term outcomes in ypT2 rectal cancer patients after neoadjuvant therapy and local excision: a multicentre observational study
por: Peltrini, Roberto, et al.
Publicado: (2022)

Evaluating Variations of Bladder Volume Using an Ultrasound Scanner in Rectal Cancer Patients during Chemoradiation: Is Protocol-Based Full Bladder Maintenance Using a Bladder Scanner Useful to Maintain the Bladder Volume?
por: Yoon, Hong In, et al.
Publicado: (2015)

Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial
por: Lee, Jii Bum, et al.
Publicado: (2020)

Clinical outcomes for T(1-2)N(0-1 )oral tongue cancer patients underwent surgery with and without postoperative radiotherapy
por: Shim, Su Jung, et al.
Publicado: (2010)

Impact of Adjuvant Chemotherapy Completion on Oncologic Outcomes in ypTNMstage 2 Rectal Cancer Patients
por: Park, Youn Young, et al.
Publicado: (2019)

Optimal timing of surgery after neoadjuvant chemoradiation therapy in locally advanced rectal cancer
por: Jeong, Duck Hyoun, et al.
Publicado: (2013)

Simple calculation using anatomical features on pre-treatment verification CT for bladder volume estimation during radiation therapy for rectal cancer
por: Kim, Nalee, et al.
Publicado: (2020)

Clinical Impact of Tumor Regression Grade after Preoperative Chemoradiation for Locally Advanced Rectal Cancer: Subset Analyses in Lymph Node Negative Patients
por: Min, Byung Soh, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_r2kr0mrkll622komqtoq67f0sd